YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD

Yunnan Botanee Bio-Technology Group Co.LTD

300957

CNE100004G74

Personal Products

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-19 EDT			5-day change	1st Jan Change
58.2 ^CNY	-0.15%		+0.14%	-14.63%

04-29	Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 62 Yuan From 87 Yuan, Keeps at Hold	MT
04-26	Yunnan Botanee Bio-Technology Group Co.LTD Proposes Final Dividend for 2023	CI

Weimai Medical Technology Co., Ltd. announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD

October 26, 2023

Weimai Medical Technology (Wuxi) Co., Ltd. announced that it has raised in a round of funding on October 27, 2023. The transaction included participation from new investor, Yunnan Botanee Bio-Technology Group Co.LTD.

Latest news about Yunnan Botanee Bio-Technology Group Co.LTD

Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 62 Yuan From 87 Yuan, Keeps at Hold	04-29	MT
Yunnan Botanee Bio-Technology Group Co.LTD Proposes Final Dividend for 2023	04-26	CI
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Full Year Ended December 31, 2023	04-25	CI
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023.	04-01	CI
Certain A Shares of Yunnan Botanee Bio-Technology Group Co.LTD are subject to a Lock-Up Agreement Ending on 25-MAR-2024.	03-24	CI
Weimai Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Yunnan Botanee Bio-Technology Group Co.LTD	03-14	CI
Weimai Qingtong Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd.	03-12	CI
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023.	01-02	CI
In China's slowing beauty market, big brand discounts won't cut it	12-07	RE
Shanghai Weimu Medical Technology Co., Ltd. announced that it has received CNY 100 million in funding from Yunnan Botanee Bio-Technology Group Co.LTD, Huajin Avenue Investment Co., Ltd., SHAREWIN Equity Investment and Management Co., Ltd., Shanghai CS Capital Co., Ltd, Sinvo Capital Holdings Co., Ltd., Investment Arm, IDG Capital Partners Co., Ltd.	12-05	CI
Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 87 Yuan From 105 Yuan, Keeps at Hold	23-10-31	MT
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
Yunnan Botanee Bio-Technology Group Co.LTD announces an Increase in Equity Buyback.	23-10-26	CI
Weimai Medical Technology Co., Ltd. announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD	23-10-26	CI
Yunnan Botanee Bio-Technology Group Co.LTD announces an Equity Buyback for CNY 200 million worth of its shares.	23-08-30	CI
Yunnan Botanee Bio-Technology Group Co.LTD authorizes a Buyback Plan.	23-08-29	CI
Yunnan Botanee’s H1 Profit Jumps 14% as Revenue Grows 15.5%	23-08-29	MT
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Shanghai Ruishi Health Technology Co., Ltd. announced that it has received CNY 100 million in funding from BRV Partners, LLC, Yaojin Private Equity Fund Management Co., Ltd., Sinovation Ventures Enterprise Management Limited, Yunnan Botanee Bio-Technology Group Co.LTD	23-08-08	CI
Yunnan Botanee Seeks to Double Revenue in Three Years	23-07-13	MT
Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 105 Yuan From 132 Yuan, Keeps at Hold	23-07-13	MT
Yunnan Botanee Bio-Technology Group Co.LTD Implements Final Profit Distribution Plan of A Shares for 2022, Payable on 30 May 2023	23-05-24	CI
Yunnan Botanee Bio-Technology Group Co.Ltd Announces Cash Dividend for 2022	23-05-18	CI
Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 132 Yuan From 145 Yuan, Keeps at Hold	23-04-28	MT

Chart Yunnan Botanee Bio-Technology Group Co.LTD

Duration

Period

Chart Yunnan Botanee Bio-Technology Group Co.LTD

More charts

Company Profile

Yunnan Botanee Bio-Technology Group Co LTD is a Chinese company mainly engaged in the production of cosmetics. The Company adopts a sales model based on offline channel sales and online channel sales as the leading factor. The Company's products mainly include creams, skin care lotions, facial masks, essences, lotions and other skin care products and make-up products such as isolation creams, blemish balm (BB) creams, and makeup removers. The Company is also engaged in the research and development, production and sales of skin care-related medical device products, mainly including hyaluronic acid repairing biofilm, hyaluronic acid repairing dressings, mainly used for the protection of skin with damaged barriers after minimally invasive surgery and care.

Sector

Personal Products

Calendar

2024-05-22 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Yunnan Botanee Bio-Technology Group Co.LTD

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

58.2 CNY

Average target price

75.99 CNY

Spread / Average Target

+30.57%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD	-14.63%	3.38B
KAO CORPORATION	+20.12%	20.76B
GALDERMA GROUP AG	0.00%	19.32B
SHISEIDO COMPANY, LIMITED	+11.99%	12.59B
COTY INC.	-15.78%	9.03B
AMOREPACIFIC CORPORATION	+23.93%	8.1B
PROYA COSMETICS CO.,LTD.	+9.36%	5.93B
NATURA &CO HOLDING S.A.	-2.84%	4.46B
INTER PARFUMS, INC.	-17.38%	3.81B
KOSÉ CORPORATION	-9.91%	3.59B

Cosmetics & Perfumes

Yunnan Botanee Bio-Technology Group Co.LTD

Equities

300957

CNE100004G74

Personal Products

Weimai Medical Technology Co., Ltd. announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD

EPS Revisions